Efficacy and safety of camrelizumab plus apatinib in previously treated patients with advanced non-small cell lung cancer harboring EGFR or ALK genetic aberration
暂无分享,去创建一个
Jianxing He | R. Guo | Jun Zhao | S. Ren | Caicun Zhou | G. Gao | Quanren Wang | K. Gu | M. Fan | A. Zang | Zhehai Wang | S. Cang | Yueyin Pan | J. Ni | Xiaoyan Lin | Yina Wang | Zhihua Liu | Weixia Li | Xin-Min Yang | Yunpeng Liu | Zhiyong Ma | Gongyan Chen